
Sign up to save your podcasts
Or
In this episode, Dr. Cedric O’Gorman, from Axsome Therapeutics, reports on efficacy and safety data for their pipeline acute medication, AXS-07, which is a combination of the NSAID meloxicam and rizatriptan.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
4.7
2929 ratings
In this episode, Dr. Cedric O’Gorman, from Axsome Therapeutics, reports on efficacy and safety data for their pipeline acute medication, AXS-07, which is a combination of the NSAID meloxicam and rizatriptan.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
43,610 Listeners
12,625 Listeners
2,462 Listeners
31,882 Listeners
3,556 Listeners
8,025 Listeners
269 Listeners
25 Listeners
6,447 Listeners
57,635 Listeners
26 Listeners
2,048 Listeners
19,601 Listeners
8 Listeners
3,594 Listeners